KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EPAM Systems (EPAM) Asset Writedowns and Impairment (2016 - 2025)

EPAM Systems (EPAM) has disclosed Asset Writedowns and Impairment for 15 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 238.62% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 141.21% increase, with the full-year FY2025 number at $1.8 million, up 141.21% from a year prior.
  • Asset Writedowns and Impairment was $1.8 million for Q4 2025 at EPAM Systems, up from -$200000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $12.3 million in Q2 2022 to a low of -$8.8 million in Q4 2022.
  • A 5-year average of $798450.0 and a median of -$9000.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: surged 777.11% in 2021, then crashed 890.11% in 2024.
  • EPAM Systems' Asset Writedowns and Impairment stood at -$2.4 million in 2021, then crashed by 263.03% to -$8.8 million in 2022, then skyrocketed by 160.46% to $5.3 million in 2023, then tumbled by 124.97% to -$1.3 million in 2024, then skyrocketed by 238.62% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for EPAM's Asset Writedowns and Impairment are $1.8 million (Q4 2025), -$200000.0 (Q3 2025), and $387000.0 (Q2 2025).